Multiple risk factors ware found to affect the prognosis of soft tissue sar­coma. They include age, sex, histolog-ic type and grade, tumour site and size (Rooseretal., 1988). Rhabdomyosarcoma is the most common pediatric soft tissue sarcoma (Young and Miller, 1975). Overall sur­vival rates have increased from less than 20 % in 1960 to as high as 70 % { Creen and Jaffe, 1978 ). Appropriate therapy is developed by integrating surgery, radiation therapy and chemo­therapy with supportive care (Ghavimi etal., 1975). The potential for chemotherapy and radiation therapy to control gross and microscopic metastatic disease decreases the need of aggressive sur­gery which result in functional and cosmetic morbidity, the optimum se­quencing as well as the extent of sur­gery, radiation therapy and chemo­therapy are continually evolving. The aim of this retrospective work is to study and analyse the clinicoe-pidemiologic characters of pediatric soft tissue sarcoma with review of treatment and survival.